Cullinan Therapeutics, Inc. CGEM Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 10.3×0.0× | 10.2×-0.2× | 10.4×+0.6× | 9.8×-1.8× | 11.6×-1.9× | |
| Valuation | ||||||
| Market capitalization | $1.08B+140% | $611.44M+74.5% | $350.31M-24.3% | $462.67M+4.5% | $442.94M-37.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Cullinan Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Cullinan Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.